Obesity Among HIV-Infected Adults Receiving Medical Care in the United States: Data From the Cross-Sectional Medical Monitoring Project and National Health and Nutrition Examination Survey
Overview
Authors
Affiliations
Our objective was to compare obesity prevalence among human immunodeficiency virus (HIV)-infected adults receiving care and the U.S. general population and identify obesity correlates among HIV-infected men and women.Cross-sectional data was collected in 2009 to 2010 from 2 nationally representative surveys: Medical Monitoring Project (MMP) and National Health and Nutrition Examination Survey (NHANES).Weighted prevalence estimates of obesity, defined as body mass index ≥30.0 kg/m, were compared using prevalence ratios (PR, 95% confidence interval [CI]). Correlates of obesity in HIV-infected adults were examined using multivariable logistic regression.Demographic characteristics of the 4006 HIV-infected adults in MMP differed from the 5657 adults from the general U.S. population in NHANES, including more men (73.2% in MMP versus 49.4% in NHANES, respectively), black or African Americans (41.5% versus 11.6%), persons with annual incomes <$20,000 (64.5% versus 21.9%), and homosexuals or bisexuals (50.9% versus 3.9%). HIV-infected men were less likely to be obese (PR 0.5, CI 0.5-0.6) and HIV-infected women were more likely to be obese (PR1.2, CI 1.1-1.3) compared with men and women in the general population, respectively. Among HIV-infected women, younger age was associated with obesity (<40 versus >60 years). Among HIV-infected men, correlates of obesity included black or African American race/ethnicity, annual income >$20,000 and <$50,000, heterosexual orientation, and geometric mean CD4+ T-lymphocyte cell count >200 cells/μL.Obesity is common, affecting 2 in 5 HIV-infected women and 1 in 5 HIV-infected men. Correlates of obesity differ for HIV-infected men and women; therefore, different strategies may be needed for the prevention and treatment.
Koffi J, Plaisy M, Djaha J, Minga A, Ngoran S, Boni S BMC Public Health. 2025; 25(1):555.
PMID: 39930397 PMC: 11812185. DOI: 10.1186/s12889-025-21715-6.
Herce M, Bosomprah S, Masiye F, Mweemba O, Edwards J, Mandyata C Implement Sci Commun. 2024; 5(1):61.
PMID: 38844992 PMC: 11155136. DOI: 10.1186/s43058-024-00601-z.
Abel J, Allen O, Bullock D, Finley E, Walter E, Schnarrs P J Health Dispar Res Pract. 2024; 12(2).
PMID: 38828271 PMC: 11141404.
Human Immunodeficiency Virus as a Risk Factor for Cardiovascular Disease.
Lembas A, Zaleski A, Peller M, Mikula T, Wiercinska-Drapalo A Cardiovasc Toxicol. 2023; 24(1):1-14.
PMID: 37982976 PMC: 10838226. DOI: 10.1007/s12012-023-09815-4.
Li T, Sun L, He Y, Zhou Y, Xu L, Zhao F Front Public Health. 2023; 11:1186838.
PMID: 37900013 PMC: 10602863. DOI: 10.3389/fpubh.2023.1186838.